Search NLS News

Exact Therapeutics has announced that its collaboration partner GE Healthcare has been awarded with an innovation grant from the Norwegian Research Council (NRC) of 16 million NOK to support the development of a ready-to-use formulation of Sonazoid for ultrasound imaging and therapy. “We are very pleased with the award of this NRC grant, which brings […]

The US company has announced an agreement to acquire SDS Life Science AB and SDS MedteQ AB. With SDS Life Science and SDS MedteQ supporting more than 100 biomedical sponsors in Scandinavia, in addition to several multinational pharmaceutical companies, the acquisition continues Cytel’s rapid growth into new global markets, the company states in a press […]

Genomic Medicine Sweden, GMS, has entered into an agreement with the Swedish life science sector’s trade associations to promote industry collaboration. The aim is to jointly strengthen national conditions for precision medicine. “For GMS, this agreement is a step towards creating improved and strengthened conditions for collaboration with industry. Through structured work, we will become […]

BerGenBio has announced the initiation of a trial evaluating bemcentinib in combination with the current standard of care, checkpoint inhibitor pembrolizumab and doublet chemotherapy, for the treatment of 1st line Non-Small Cell Lung Cancer patients harboring STK11 mutations. “Real-world data continues to reinforce that the presence of STK11m currently result in particularly poor outcomes for […]

Nykode Therapeutics has announced clinical results from the open label, dose escalation trial of its T cell focused pan-SARS-CoV-2 vaccine candidate (VB10.2210) in healthy individuals who were previously vaccinated with an approved mRNA vaccine. T cell responses were analyzed by ex vivo ELISpot up until day 35. VB10.2210 induced broad and strong T cell responses, […]

SciLifeLab has welcomed their Majesties from the Netherlands and Sweden to learn more about technologies to study cells and initiatives for precision medicine. “It is a major recognition for SciLifeLab to be selected as a site for this state visit and it was our pleasure to guide these distinguished visitors through a glimpse of the […]

Mendus will receive 1.69 million EUR as the final grant payment from the Horizon 2020-funded AML-VACCiN project. All requirements for the final tranche have been fulfilled, bringing the total financial contribution from the European Commission to 6.0 million EUR for the project as a whole. As a result of the project completion, Mendus is now […]

The two agreements are with companies that are also active in the development of drugs for both liver and kidney fibrosis. “The contracts with our new clients clearly show that pharmaceutical companies continue to invest in the development of new drugs for fibrosis, which is extremely promising for InfiCure Bio,” says InfiCure Bio’s CEO, Sofia […]

DoMore Diagnostics, one of our NLS Stars 2022, aims to change the one-size-fits-all approach in cancer therapy. Cancer is a growing global public health problem, and the cost of cancer care is expected to double the next 20 years. It is a leading cause of death worldwide and accounted for nearly 10 million deaths in […]

TILT Biotherapeutics has announced that the first US patient has been dosed in its ovarian cancer trial, using its oncolytic adenovirus, TILT-123. This open-label, phase I, dose-escalation, multicenter, and multinational, clinical trial of TILT-123 in combination with MSD’s anti-PD-1 therapy, KEYTRUDA (pembrolizumab), is for platinum resistant or refractory ovarian cancer (PROTA, also called TILT-T563). The […]